MYHUMANI LTD

Company number 15433401 ·

Active

Executive summary

MYHUMANI LTD presents a low immediate financial risk based on its current balance sheet and regulatory compliance, despite its early stage and small scale. Investor concerns primarily relate to limited operational history and concentrated ownership, which warrant further due diligence on business viability and governance. Continued monitoring of financial performance and management capabilities is recommended before investment decisions.

Read the full AI analysis →

Shareholders' funds

£33,989

Balance sheet as at 2026-01-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2024-01-22
Employees
2 (2026 accounts)
Registered office
4 Arbury Terrace, London, England, SE26 6AP
Postcode
SE26 6AP
Accounts category
Micro

Accounts

Last made up to
2026-01-31
Next due by
2027-10-31
Financial year end
31 January

Confirmation statement

Last statement dated
2026-01-27
Next due by
2027-02-10
View filing history →

Nature of business (SIC)

  • 47789 Other retail sale of new goods in specialised stores (not commercial art galleries and opticians)
  • 64991 Security dealing on own account
  • 70229 Management consultancy activities other than financial management
  • 86900 Other human health activities

Officers 2 current

Appointed 2024-02-09
Martin SIKULA Director
Appointed 2024-01-22

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZB851788 (Tier 1), registered since 2025.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Competitors London

This company ranks 24 among other retail sale of new goods in specialised stores (not commercial art galleries and opticians) in London.

Full league table →

This company's registered activities are in financial services. If it carries on regulated business, it should appear on the FCA's Financial Services Register — the official record of authorised firms.